BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Hepatology

The World Journal of Hepatology (WJH) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of hepatology.  It was launched on October 31, 2009 and is published three issues per month (36 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage hepatologists worldwide to submit manuscripts to the WJH describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJH are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks.The WJH’s acceptance rate: 51%. Submit here >>

2016 Published Issues

Clara Balsano, PhD, Professor; Wan-Long Chuang, MD, PhD, Doctor, Professor


PubMed, PubMed Central.

Journal Metrics

SJR (SCImago Journal Rank) (2015): 0.858; IPP (Impact per Publication) (2015): 2.730; SNIP (Source Normalized Impact per Paper) (2015): 1.206.


1948-5182 (online)

Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial  
Jian-Hong Zhong, Xue-Ke Du, Bang-De Xiang, Le-Qun Li
World J Hepatol 8(23):957-960. Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.957
Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training  
Jean-Marc Lavoie
World J Hepatol 8(23):961-975. Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.961
Basic Study
Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma  
Danira Ashraf Habashy, Hend Mohamed El Tayebi, Injie Omar Fawzy, Karim Adel Hosny, Gamal Esmat, Ahmed Ihab Abdelaziz
World J Hepatol 8(23):976-984. Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.976
Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription  
Wei Wu, Jun-Ling Yang, Yi-Lang Wang, Han Wang, Min Yao, Li Wang, Juan-Juan Gu, Yin Cai, Yun Shi, Deng-Fu Yao
World J Hepatol 8(23):985-993. Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.985
Case Report
Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma  
Michael L Caparelli, Nathan J Roberts, Timothy S Braverman, Robert M Stevens, Edward R Broun, Shyam Allamaneni
World J Hepatol 8(23):994-998. Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.994